Supriya Lifescience Limited
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-02-10
Analyst
Masu Capital Partners
Equibles does not estimate personal net worth.
Shyam Sampar is recorded as Analyst at Masu Capital Partners. Shyam Sampar has spoken on 1 earnings call across 1 company, most recently for Supriya Lifescience Limited on February 10, 2026. The companies whose calls Shyam Sampar spoke on are classified in the Healthcare sector.
“I wanted to ask on the ATS order book for FY27. The MIP protects us, but are we seeing any risk of customers shifting to ATS 9 and bypassing the ban, like in the context of formulators giving supply security and locking an annual volume contract?”
Masu Capital Partners
Analyst
Transcript header (unverified)
Supriya Lifescience Limited
Biotechnology · Healthcare
Supriya Lifescience Limited Q3 FY '26 Earnings Conference Call
Supriya Lifescience Limited